RA CAPITAL MANAGEMENT, L.P. sold 15.7% of their position (849.26K shares) of VOR BIOPHARMA INC. on the open market
Open‑market sale worth $14.52M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/6/2026ACC: 0001231919-26-000320
Director10% Owner
Since Feb 2021
-849.26K
Net shares
Net seller
$14.52M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
849.26K disposed
Non-Derivative Transactions5
Common Stock
Indirect
Shares
−258.48K
Price / share
$18.23
Trade value
$4.71M
% of position
4.8%
4/2/2026
5.40M→5.15M
Common Stock
Indirect
Shares
−1.52K
Price / share
$19.06
Trade value
$29.07K
% of position
0.0%
4/2/2026
5.15M→5.14M
Common Stock
Indirect
Shares
−537.75K
Price / share
$16.51
Trade value
$8.88M
% of position
10.5%
4/6/2026
5.14M→4.61M
Common Stock
Indirect
Shares
−44.73K
Price / share
$17.31
Trade value
$774.24K
% of position
1.0%
4/6/2026
4.61M→4.56M
Common Stock
Indirect
Shares
−6.78K
Price / share
$18.50
Trade value
$125.34K
% of position
0.1%
4/6/2026
4.56M→4.56M
Total
Net shares
−849.26K
Net value
-$14.52M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/2/2026 | S · Sale | −258.48K | $18.23 | $4.71M | 4.8% | 5.40M | 5.15M |
| Common Stock Indirect | 4/2/2026 | S · Sale | −1.52K | $19.06 | $29.07K | 0.0% | 5.15M | 5.14M |
| Common Stock Indirect | 4/6/2026 | S · Sale | −537.75K | $16.51 | $8.88M | 10.5% | 5.14M | 4.61M |
| Common Stock Indirect | 4/6/2026 | S · Sale | −44.73K | $17.31 | $774.24K | 1.0% | 4.61M | 4.56M |
| Common Stock Indirect | 4/6/2026 | S · Sale | −6.78K | $18.50 | $125.34K | 0.1% | 4.56M | 4.56M |
| Total | −849.26K | -$14.52M | ||||||
Derivative Transactions0
No derivative transactions reported